Clinical Trial Update: Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating conditioning with an Umbilical Cord Blood Transplant for hematologic malignancies has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Umbilical Cord Blood Transplant

Snippet

Sponsor: University of Virginia | Conditions: Hematologic Malignancies | Phase 2 | Status: TERMINATED